Full Terms & Conditions of access and use can be found at http://www.tandfonline.com/action/journalInformation?journalCode=iipi20 Download by: [Akdeniz Universitesi] Date: 28 July 2017, At: 03:50 Immunopharmacology and Immunotoxicology ISSN: 0892-3973 (Print) 1532-2513 (Online) Journal homepage: http://www.tandfonline.com/loi/iipi20 Omalizumab (anti-IgE) therapy in the asthma–COPD overlap syndrome (ACOS) and its effects on circulating cytokine levels Arzu Didem Yalcin, Betul Celik & Ata Nevzat Yalcin To cite this article: Arzu Didem Yalcin, Betul Celik & Ata Nevzat Yalcin (2016) Omalizumab (anti-IgE) therapy in the asthma–COPD overlap syndrome (ACOS) and its effects on circulating cytokine levels, Immunopharmacology and Immunotoxicology, 38:3, 253-256, DOI: 10.3109/08923973.2016.1173057 To link to this article: http://dx.doi.org/10.3109/08923973.2016.1173057 Published online: 28 Apr 2016. Submit your article to this journal Article views: 431 View related articles View Crossmark data Citing articles: 9 View citing articles